Meeting reports

The 2024 Future Investigators of Regenerative Medicine (FIRM) Symposium highlighted groundbreaking research in regenerative medicine and tissue engineering. Key points of discussion included advanced scientific developments within the field, a panel discussion on diverse career options for postgraduate students in both academia and industry, and a CV workshop providing guidance to our early-career delegates to prepare for their professional development.

Notable research presented during the symposium featured innovations such as multiscale biofabrication for biological systems, molecular biomaterials aimed at improving regenerative medicine, and cutting-edge therapies for nerve regeneration. Additionally, efforts to build platforms for the commercialisation of advanced therapy medicinal products (ATMPs) were introduced. Alongside these keynotes, delegates showcased their versatile projects, contributing valuable insights into the future of tissue engineering and regenerative medicine.

Biochemical Society funding was used to support one of the keynote sessions and for prizes awarded at the meeting.

The key takeaways from FIRM 2024 focused on the importance of communication and collaboration within the field, offering a platform for the exchange of current research. Participants also gained invaluable perspectives on professional development, including guidance on how PhD students can best prepare for diverse career opportunities in both industry and academia, solidifying FIRM’s role as a catalyst for growth and innovation in regenerative medicine.

www.firmsymposium.com